BIO-RAD C1000 Thermal Cycler CFX96 Real-Time PCR System, Used, 120V
BIO-RAD
Details
-
CategoryOther
-
Dimension20.0in x 18.0in x 16.0in
-
SerialCC015451
-
Shipping TypeFedEx Ground
-
Voltage / Hertz120V / 50Hz/60Hz
Description
Presenting the BIO-RAD C1000 Thermal Cycler with CFX96 Real-Time System, a versatile and fully functional unit in very good condition. This used thermal cycler is ideal for laboratories conducting gene expression studies or running high-throughput experiments. The system incorporates an interchangeable reaction module, facilitating exceptional thermal cycling and data accuracy. Its intuitive software, factory-calibrated optics, and thermal gradient feature streamline the PCR process, delivering optimal results with minimal sample volumes. Perfect for laboratories seeking reliable, fast, and efficient quantitative PCR solutions.
Key Features
- Interchangeable reaction module for enhanced flexibility
- Factory-calibrated optics for quick installation
- Thermal gradient feature for reaction optimization
- Fast thermal cycling with results in <30 minutes
- Compatibility with low sample volumes
Specifications
- Brand: BIO-RAD
- Model: C1000
- Voltage: 120V
- Frequency: 50Hz/60Hz
- Condition: VG (Very Good), Used
- Interchangeable Reaction Module
- Thermal Gradient Capability
- Maximized Reliability with Long-lasting LEDs
Weight
Imperial: 48.0 Pounds
Metric: 21.77 Kilograms
Shipping Dimensions
Imperial: 24.0 lb x 21.6 lb x 19.2 lb
Metric: 60.96 cm x 54.86 cm x 48.77 cm
Harmonized Code
9027.20.40
Harmonized Code Details
Harmonized code 9027.20.40 applies to PCR equipment, which includes thermal cyclers designed for biotechnology laboratories. This code is appropriate given the equipment's application in PCR analysis.
Product Enquiry
Have a question about this product? Send us your enquiry and our sales team will get back to you shortly.
Product Make Offer
Submit your best offer for this product. Our sales team will review your request and connect with you as soon as possible.
Comments 0
There are currently no public comments.